Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.990
-0.020 (-0.50%)
At close: Nov 28, 2025, 1:00 PM
4.090
+0.100 (2.51%)
After-hours: Nov 28, 2025, 3:21 PM EST
Apyx Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Apyx Medical stock has a target of 8.00, which predicts a 100.50% increase from the current stock price of 3.99.
Price Target: $8.00 (+100.50%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for Apyx Medical is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Hold → Buy Upgrades $8 | Hold → Buy | Upgrades | $8 | +100.50% | Nov 12, 2025 |
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +25.31% | Nov 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +12.78% | Aug 11, 2023 |
Financial Forecast
Revenue This Year
51.00M
from 48.10M
Increased by 6.03%
Revenue Next Year
53.54M
from 51.00M
Increased by 4.97%
EPS This Year
-0.37
from -0.66
EPS Next Year
-0.43
from -0.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 52.5M | 55.2M | ||||
| Avg | 51.0M | 53.5M | ||||
| Low | 49.0M | 51.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.2% | 8.2% | ||||
| Avg | 6.0% | 5.0% | ||||
| Low | 1.9% | 0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.35 | -0.42 | |
| Avg | -0.37 | -0.43 | |
| Low | -0.41 | -0.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.